Function Health, founded in 2022, is revolutionizing personal healthcare by offering an annual subscription service that includes over 100 lab tests and insights from top doctors for $499. They empower individuals to take charge of their health by providing comprehensive monitoring across various health areas such as heart health, thyroid, cancer detection, and more.
The company recently secured a substantial $200.00M in a Series B investment round on 01 May 2025. This funding reflects strong investor confidence and positions the company for significant growth. The investment was backed by notable firms and individuals, including 1843 Capital, FirstMark, Andreessen Horowitz (a16z), SV Angel, BroadLight Capital, and celebrity investors like Matt Damon.
With this influx of capital, Function Health is poised to expand its service offerings and enhance its platform, driving further innovation in the healthcare space. Their consumer-centric approach and sprawling investor support make them a promising player to watch in the health tech industry.
